Cargando…

Correction: Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs

Detalles Bibliográficos
Autores principales:	Lussier, Yves A., Khodarev, Nikolai N., Regan, Kelly, Corbin, Kimberly, Li, Haiquan, Ganai, Sabha, Khan, Sajid A., Gnerlich, Jennifer L., Darga, Thomas E., Fan, Hanli, Karpenko, Oleksiy, Paty, Philip B., Posner, Mitchell C., Chmura, Steven J., Hellman, Samuel, Ferguson, Mark K., Weichselbaum, Ralph R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676315/ http://dx.doi.org/10.1371/annotation/2489ae5e-3650-4897-8df6-3e974ca585c4

Ejemplares similares

Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs
por: Lussier, Yves A., et al.
Publicado: (2012)

MicroRNA Expression Characterizes Oligometastasis(es)
por: Lussier, Yves A., et al.
Publicado: (2011)

Exploring the microRNA profiles as potential diagnostic probes for oligo- and polymetastatic prognosis of lung metastasis(es) patients
por: Wang, Zhichao, et al.
Publicado: (2018)

Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer
por: Xu, Li-Ming, et al.
Publicado: (2017)

Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies
por: Petrelli, Fausto, et al.
Publicado: (2022)

Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs
por: Uppal, Abhineet, et al.
Publicado: (2014)

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
por: Pitroda, Sean P., et al.
Publicado: (2018)

Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
por: Pitroda, Sean P., et al.
Publicado: (2018)

Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model
por: Uppal, Abhineet, et al.
Publicado: (2014)

Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome
por: Wightman, S C, et al.
Publicado: (2015)

Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling
por: Efimova, Elena V., et al.
Publicado: (2009)

14q32-encoded microRNAs mediate an oligometastatic phenotype
por: Uppal, Abhineet, et al.
Publicado: (2015)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer
por: Shirasawa, Masayuki, et al.
Publicado: (2019)

Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression
por: Sun, Zhiwei, et al.
Publicado: (2018)

Imaging of tumor clones with differential liver colonization
por: Oshima, Go, et al.
Publicado: (2015)

STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy
por: Khodarev, Nikolai N., et al.
Publicado: (2009)

Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia
por: McCormick, Susan, et al.
Publicado: (2015)

Tumor Endothelial Inflammation Predicts Clinical Outcome in Diverse Human Cancers
por: Pitroda, Sean P., et al.
Publicado: (2012)

Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
por: Ranoa, Diana Rose E., et al.
Publicado: (2016)

Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial
por: Corkum, Mark T., et al.
Publicado: (2021)

Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy
por: Bauman, Glenn S., et al.
Publicado: (2021)

Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
por: Sun, Zhiwei, et al.
Publicado: (2021)

Tumor-reprogrammed resident T cells resist radiation to control tumors
por: Arina, Ainhoa, et al.
Publicado: (2019)

OligoRAP – an Oligo Re-Annotation Pipeline to improve annotation and estimate target specificity
por: Neerincx, Pieter BT, et al.
Publicado: (2009)

Polar tagging in the synthesis of monodisperse oligo(p-phenyleneethynylene)s and an update on the synthesis of oligoPPEs
por: Sahoo, Dhananjaya, et al.
Publicado: (2010)

Oligo‐Quinolylene–Vinylene Foldamers
por: Wang, Jinhua, et al.
Publicado: (2020)

Nano-RNases: oligo- or dinucleases?
por: Lee, Vincent T, et al.
Publicado: (2022)

Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors
por: Cha, Yu Jin, et al.
Publicado: (2017)

COOPERATIVITY OF THE MUC1 ONCOPROTEIN AND STAT1 PATHWAY IN POOR PROGNOSIS HUMAN BREAST CANCER
por: Khodarev, Nikolai, et al.
Publicado: (2009)

Using GIS for spatial analysis of rectal lesions in the human body
por: Garb, Jane L, et al.
Publicado: (2007)

In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis
por: Ganai, Sabha, et al.
Publicado: (2011)

Disparities in long-term radiographic follow-up after cystectomy for bladder cancer: Analysis of the SEER-Medicare database
por: Alanee, Shaheen, et al.
Publicado: (2016)

The Solution Properties of Polymethacrylate Molecular Brushes with Oligo(ethylene glycol) and Oligo(propylene glycol) Side Chains
por: Simonova, Maria, et al.
Publicado: (2022)

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients
por: MacDermed, Dhara M, et al.
Publicado: (2010)

STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect
por: Pitroda, Sean P, et al.
Publicado: (2009)

Oligometastases/Oligo-Recurrence of Lung Cancer
por: Niibe, Yuzuru, et al.
Publicado: (2013)

BOND: Basic OligoNucleotide Design
por: Ilie, Lucian, et al.
Publicado: (2013)

Conjugated Oligo- and Polymers for Bacterial Sensing
por: Löffler, Susanne, et al.
Publicado: (2019)

Site-Selective Modification of (Oligo)Saccharides
por: Witte, Martin D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jlu6jice9cst092fe7m7l86cml